Last reviewed · How we verify

NCT06244589

Evaluation of Risk Factors Leading to Conversion From Laparoscopic Cholecystectomy to Open Surgery

Completed NA Last updated 29 May 2024
What this trial tests

NA trial testing Laparoscopic cholecystectomy in Cholelithiasis in 1,695 participants. Completed in 28 May 2024.

Timeline
12 February 2024
Primary endpoint
28 May 2024
28 May 2024

Quick facts

Lead sponsorSisli Hamidiye Etfal Training and Research Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment1,695
Start date12 February 2024
Primary completion28 May 2024
Estimated completion28 May 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sisli Hamidiye Etfal Training and Research Hospital

Who can join

Adults 18 to 95, any sex, with Cholelithiasis or Cholecystitis, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective controlled study aims to evaluate risk factors that affect open conversion in laparoscopic cholecystectomy. Patient characteristics, medical history, biochemical and radiological studies of the patient will searched from the hospital database and factors affecting open conversion will be analysed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation of Risk Factors Leading to Conversion from Laparoscopic Cholecystectomy to Open Surgery: A Retrospective Controlled Study.
    Dinçer B, Ömeroğlu S, Tufan AE, Uzun MA. · · 2025 · cited 3× · PMID 39992726 · DOI 10.1089/lap.2024.0366

Verify or expand the search:

Other trials of Laparoscopic cholecystectomy

Trials testing the same drug.

Other recruiting trials for Cholelithiasis

Currently open trials in the same condition.

Other Sisli Hamidiye Etfal Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06244589.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing